3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms, Castration-Resistant
1
Prostatic Neoplasms
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Metastatic Castrate Resistant Prostate Cancer
1
Interventions
enzalutamide
4
abiraterone
2
Docetaxel
2
tasquinimod
1
sabizabulin
1
olaparib
1
ipatasertib
1
darolutamide
1
atezolizumab
1
Nivolumab
1
Abiraterone Acetate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Prostatic Neoplasms, Castration-Resistant
×
tasquinimod
×
Clear all
NCT02057666
2021-04-23
TasQ003
Ipsen
Phase 3
Terminated
146 enrolled
13 charts